Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New Zealand Dairy Board was the statutory monopoly exporter for New Zealand's dairy industry until its merger to form Fonterra in 2001. Beyond its marketing role, the board was a significant driver of life science research through its management of dairy-derived bioactive compounds and functional ingredients. It spearheaded the development of specialized nutritional products, including proprietary probiotic strains and high-value protein fractions for medical and infant nutrition. The organization's research legacy established New Zealand as a global leader in the nutraceutical and functional food sectors. Today, its former assets and intellectual property form the core of Fonterra's specialized nutrition business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Zealand Dairy Board.